Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Fıratlı Tuğlular T"" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł :
Quality of Life and Symptom Burden With First- and Second-generation Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myeloid Leukemia.
Autorzy :
Bostan H; Department of Internal Medicine, Marmara University Medical Faculty, İstanbul, Turkey; Department of Endocrinology and Metabolism, University of Health Sciences, Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey. Electronic address: .
Toptas T; Department of Hematology, Marmara University Medical Faculty, İstanbul, Turkey.
Tanrikulu FP; Department of Hematology, Adana State Training and Research Hospital, Adana, Turkey.
Kut K; Department of Hematology, Marmara University Medical Faculty, İstanbul, Turkey.
Arikan F; Department of Hematology, Marmara University Medical Faculty, İstanbul, Turkey.
Yilmaz F; Department of Hematology, Marmara University Medical Faculty, İstanbul, Turkey.
Atagunduz I; Department of Hematology, Marmara University Medical Faculty, İstanbul, Turkey.
Firatli-Tuglular T; Department of Hematology, Marmara University Medical Faculty, İstanbul, Turkey.
Pokaż więcej
Źródło :
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2020 Dec; Vol. 20 (12), pp. 836-842. Date of Electronic Publication: 2020 Aug 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate.
Autorzy :
Kaygusuz Atagunduz I; Department of Hematology, Marmara University Hospital, Istanbul, Turkey. Electronic address: .
Toptas T; Department of Hematology, Marmara University Hospital, Istanbul, Turkey.
Deniz R; Department of Internal Medicine, Marmara University Hospital, Istanbul, Turkey.
Kara O; Department of Hematology, Marmara University Hospital, Istanbul, Turkey.
Eser A; Department of Hematology, Marmara University Hospital, Istanbul, Turkey.
Sezgin A; Department of Hematology, Marmara University Hospital, Istanbul, Turkey.
Ozgumus T; Department of Hematology, Marmara University Hospital, Istanbul, Turkey.
Gecgel F; Department of Hematology, Marmara University Hospital, Istanbul, Turkey.
Firatli Tuglular T; Department of Hematology, Marmara University Hospital, Istanbul, Turkey.
Pokaż więcej
Źródło :
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2017 Feb; Vol. 17 (2), pp. 120-125. Date of Electronic Publication: 2016 Sep 17.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Imatinib Mesylate/*therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Cytogenetics/methods ; Disease-Free Survival ; Female ; Fusion Proteins, bcr-abl/metabolism ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/mortality ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Relationship of P-selectin glycoprotein ligand-1 to prognosis in patients with multiple myeloma.
Autorzy :
Atalay F; Department of Hematology, Baskent University School of Medicine, İstanbul, Turkey. Electronic address: .
Ateşoğlu EB; Department of Hematology, Kocaeli University School of Medicine, Kocaeli, Turkey.
Yıldız S; Department of Pathology, Baskent University School of Medicine, İstanbul, Turkey.
Firatlı-Tuglular T; Department of Hematology, Marmara University School of Medicine, İstanbul, Turkey.
Karakuş S; Department of Hematology, Baskent University School of Medicine, Ankara, Turkey.
Bayık M; Department of Hematology, Academic Hospital, İstanbul, Turkey.
Pokaż więcej
Źródło :
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2015 Mar; Vol. 15 (3), pp. 164-70. Date of Electronic Publication: 2014 Sep 28.
Typ publikacji :
Journal Article
MeSH Terms :
Membrane Glycoproteins/*metabolism
Multiple Myeloma/*metabolism
Multiple Myeloma/*mortality
Aged ; Bone Marrow/metabolism ; Bone Marrow/pathology ; Disease Progression ; Female ; Humans ; Immunohistochemistry ; Male ; Membrane Glycoproteins/genetics ; Middle Aged ; Multiple Myeloma/diagnosis ; Multiple Myeloma/genetics ; Multiple Myeloma/therapy ; Neoplasm Grading ; Neoplasm Staging ; Prognosis ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies